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Abstract
Around 41% of the world’s population continue using solid fuels, including 
wood and other types of biomass, for cooking or heating their homes. Long-term 
indoor exposure to wood smoke, and biomass smoke in general, is a risk factor 
for developing chronic obstructive pulmonary disease (COPD). In some regions 
of the world, biomass exposure is a more frequent cause of COPD than exposure 
to cigarette smoke. Recently it has been described notable differences between 
COPD associated with wood smoke (WS-COPD) and that caused by tobacco 
smoking (TS-COPD): significantly less emphysema and more airway inflammation 
in WS-COPD. Recognizing these differences, some authors have suggested that 
WS-COPD should be considered a new COPD phenotype. This chapter summarizes 
the differences between WS-COPD and TS-COPD. The information about the char-
acteristics of COPD caused by other types of biomass fuels, different from wood, 
is very scarce. Accepting that the smoke derived from wood burning and tobacco 
smoking have some differences (etiology), the inhalation patterns are different 
(pathogenesis) and the physiopathological mechanisms they induce may also differ, 
we analyze if the disease caused by indoor chronic exposure to wood smoke should 
be considered as another COPD phenotype or a distinct nosological entity.
Keywords: chronic obstructive pulmonary disease (COPD), wood smoke, biomass, 
tobacco, phenotype, emphysema, chronic bronchitis, bronchial anthracofibrosis, 
indoor air pollution
1. Introduction
Solid and biomass fuels are the most important global environmental risk 
factor. Around 41% of the world’s population, over 2.8 billion people, particularly in 
developing countries, still use solid fuels, whether coal or biomass (wood, vegetable 
remains and dung), for cooking or heating their homes [1, 2]. In some countries, 
these fuels are the main source of energy for over 70% of the rural population. In 
countries where migration from rural areas to cities is high, the population of urban 
dwellers over the age of 40 years frequently has a significant history of exposure 
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to biomass fuels. One example is Colombia, where 39% of the population over 
40 years of age living in the five main cities had cooked using wood as fuel for more 
than 10 years before relocating [3].
Between 1980 and 2010, the population exposed to household air pollution 
(HAP) increased from 333 million to 646 million in sub-Saharan Africa and from 
162 million to 190 million in the eastern Mediterranean. In south-east Asia, it 
remained stable during the same period at around 1 billion people [1].
Biomass fuels are usually burnt in open fires and inefficient traditional cook-
stoves, often in poorly ventilated cooking spaces, resulting in indoor high levels of 
air pollutants including carbon monoxide (CO) and particulate matter (PM). The 
people most exposed are women who are routinely responsible for cooking and 
their young children [4].
HAP is responsible for nearly 5% of the global disease burden, making it globally 
the single most important environmental risk factor [5]. In 2017, it has been esti-
mated that HAP contributed to 1.8 million (95% CI, 1.1–2.7) deaths and 60.9 million 
(95% CI, 34.6–93.3) disability-adjusted life-years (DALYs) globally [6]. Respiratory 
disease was the leading cause of these deaths and DALYs attributable to HAP 
accounting for 38% of all deaths (0.7 million [0.4–1.0]) and 75% of all DALYs (45.7 
million [26.8–68.8] [6]. Among the premature deaths related to HAP, 20% are due to 
chronic obstructive pulmonary disease (COPD) [2].
Biomass fuels and COPD. Several systematic reviews, meta-analyses and reviews 
of evidence confirm that individuals chronically exposed to solid fuels at home have 
a higher risk of developing COPD [6–13]. In addition, people chronically exposed 
to biomass smoke also have a high risk of chronic bronchitis [10, 14, 15]. The pooled 
analysis of the Pathak’s study [7] showed that, globally, exposure to indoor air pol-
lution due to solid biomass fuels increased risk of COPD by 2.65 (95% CI, 2.13–3.31) 
and chronic bronchitis by 2.89 (95% CI, 2.18–3.82) times more compared to non-
biomass fuels. The risk of COPD was higher in Africa region (odds ratio [OR]: 3.19), 
Asia (OR: 2.88), South America (OR: 2.15), Europe (OR: 2.30) and North America 
(OR: 2.14). This distribution confirms that although the risk is higher in developing 
regions [16], the high risk is also present in developed countries, as some studies have 
shown [17, 18].
In some highly populated countries, like India and China, the exposure to 
biomass smoke is a significant risk factor for COPD, mainly in women living in 
rural zones [15, 19–24]. In some areas of India and China, this exposure is the most 
important risk factor of COPD [20–22, 25–30]. In Latin America, the PREPOCOL 
[3], the CRONICAS [31] and the PUMA [32] studies have confirmed that the use of 
biomass fuels, frequently wood, for cooking is a significant and independent risk 
factor for COPD, stronger in women from rural areas.
Although the risk of COPD from long-term indoor exposure to biomass fuels is 
particularly high in women [23, 33–36], a population study (n = 5539) showed that, 
after adjusting for age, smoking, educational level and occupational exposure, men 
exposed to wood smoke for more than 10 years had a higher risk of COPD (OR: 
1.50) [37]. The risk of COPD increases significantly with the length of exposure to 
wood smoke and with simultaneous exposure to tobacco smoke [37].
This evidence supports that HAP from burning solid fuels, including biomass, 
is the biggest worldwide risk factor for COPD [38–40]. However, the prevalence of 
biomass-related COPD has not been precisely defined. The PREPOCOL study found 
a prevalence of 6.7% in people exposed to wood smoke and not to cigarette smoke 
compared to 7.8% in people exposed to cigarette smoke and not to wood smoke [37]. 
In rural Puno, Peru, daily use of biomass fuel for cooking among women was associ-
ated with COPD (prevalence ratio: 2.22, 95% CI: 1.02–4.81) and the population 
attributable risk of COPD due to daily exposure to biomass fuel smoke was 55% [31].
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Some populational studies, however, found no association between exposure 
to biomass fuels and COPD [41, 42]. Most of the people evaluated in these stud-
ies lived near sea level, where cooking is usually done outdoors or with better 
ventilation. In contrast, many of the studies which document this association 
have included areas situated at high or intermediary altitudes, where, due to low 
temperatures, cooking is done all year round inside poorly ventilated homes as it 
occurs in winter in regions that have seasons. There is lack of standardization of 
questionnaires or other tools for evaluating the exposure to biomass smoke derived 
from cooking or heating. A recent study, from Kyrgyzstan, evaluated the preva-
lence of COPD associated with indoor contamination at different altitudes and 
found a higher prevalence of COPD at high altitude versus at low altitude (36.7% 
vs. 10.4%; p < 0.001) associated with exposure to a greater indoor contamination 
at high altitude [43].
2. Differences between WS-COPD and TS-COPD
Although the risk of COPD has been proven for all types of biomass fuels, 
studies which best characterize COPD due to this type of exposure have focused on 
COPD caused by inhalation of wood smoke (WS-COPD). Therefore, this chapter 
also focuses on the differences of WS-COPD and TS-COPD.
Core differences. A growing body of evidence supports that WS-COPD, unlike 
TS-COPD, is predominantly and markedly a disease of the airways with mild or 
minimum emphysema [44–54]. Although recent publications have focused on the 
compromise of the small airways in biomass COPD [46, 50, 52], different from 
TS-COPD, in WS-COPD there is also a notorious compromise of the central airway 
due to carbon deposition (bronchial anthracofibrosis) with plaque formation and 
reduction in the caliber of the lobar bronchi [55–57]. In addition to this fundamen-
tal pathological difference between WS-COPD and TS-COPD, there are many other 
differences that we summarize in Table 1 and review it below.
Demographic differences. Women and their children are the most exposed 
population to indoor air pollution from biomass fuels because of women are usually 
responsible for cooking meals, particularly in developing countries, spending sev-
eral hours a day in frequently poor ventilated kitchens, and keeping their children 
close to them [4, 16, 23, 30, 58, 59].
Most of the studies show that women with WS-COPD are consistently shorter 
in height and have higher body mass index (BMI) than women with TS-COPD  
[37, 44, 49, 54, 60–66]. There is not a clear explanation for this difference. In 
general, women with WS-COPD were born and have lived in rural areas as their 
ancestry, while women with TS-COPD have lived in urban areas for many years 
and many of them have urban ancestry. Therefore, it is possible that some ethnic, 
nutritional and socioeconomics conditions could be part of the explanation of the 
difference, but there is not consistent information about this.
Moreover, women with WS-COPD are older, suggesting that patients with 
this type of exposure need more time to develop the disease or are diagnosed 
later [30, 37, 44, 51, 61, 63–65, 67].
Clinical differences. Several studies have shown a high frequency of respiratory 
symptoms (cough, expectoration, and dyspnea) and chronic bronchitis in subjects 
exposed to biomass smoke [9, 10, 14, 61]. However, comparative studies between 
WS-COPD and TS-COPD have found no consistent differences. Some studies 
show that symptoms, not only cough and phlegm but dyspnea, are more frequent 
or have more impact in WS-COPD than TS-COPD [48, 61, 68, 69] but other not 
[63, 65, 70]. Rhonchus and wheezing are more frequent in WS-COPD [68]. The 









Cough and expectoration Very common Common
Chronic bronchitis Common Common
Rhonchus and wheezing Common Less common
Lung function tests
PaCO2 Higher (some studies) Less high




Reduced FEV1 Lower Higher
Bronchial hyperresponsiveness Higher Lower
DLco and DLco/VA Normal or mildly reduced More reduced
Radiography-tomography
Emphysema Uncommon and mild Common and more severe




Emphysema Mild More severe
Anthracosis Common Less common
Airway fibrosis Common Less common
Thickening of arteriole intima Common Less common
Outcomes and clinical phenotypes
Pulmonary hypertension More common Less common
Quality of life Symptoms and activities more 
compromised or similar
Similar or symptoms and 
activities less compromised
Survival Similar after adjusting for age.
Less after adjusting for age
Similar
Exacerbator phenotype Similar Similar
Asthma-COPD overlap 
phenotype
More common Less common
Emphysema phenotype Uncommon More common
WS: wood smoke; TS: tobacco smoke; BMI: body mass index; DLCO: carbon monoxide diffusing capacity; FEV1: 
forced expiratory volume in 1 second; FVC: forced vital capacity; PaCO2: carbon dioxide arterial pressure; PaO2: 
oxygen arterial pressure; SaO2: oxygen saturation; VA: alveolar volume.
Table 1. 
Differences between wood smoke COPD and tobacco smoke COPD.
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greater bronchial compromise in WS-COPD documented in several publications 
which use functional and tomographic evaluations supports the studies which 
show more frequent cough, expectoration, rhonchus and wheezing in WS-COPD.
Differences in quality of life. Using the Saint George’s Hospital Questionnaire, 
Camp et al. found worse symptoms and more impaired activity indices in women 
with WS-COPD [48]. González-Garcia et al., in 138 women with COPD, showed 
that, at the same degree of obstruction, women with WS-COPD had a worse 
health status (poorer quality of life and worse dyspnea) than those with TS-COPD, 
without differences in comorbidities (Figure 1) [68]. Some studies have not shown 
differences in quality of life between these two groups of patients [65].
Differences in lung function. Airflow obstruction, both overall and adjusted 
by age, is milder [37, 48, 54, 60–63, 65] and the FEV1 decline is slower and more 
homogeneous in WS-COPD [54, 62] than in TS-COPD. Ocakli et al. described a 
more significant compromise of FVC with higher FEV1/FVC ratio in people with 
COPD related to biomass smoke suggesting restrictive ventilatory alteration, but 
lung volumes were not measured [71]. The chronic airflow limitation in patients with 
WS-COPD is possibly due not only to the small airways compromise [46, 50, 52, 54], 
but to anthracofibrosis of the large airways [55–57].
A recent study, aimed to evaluate the lung volumes and the resistance and con-
ductance of the airways using plethysmograhy, showed that residual volumes (RV), 
Figure 1. 
Quality of life. Comparison between WS-COPD and TS-COPD. WS-COPD: wood-smoke COPD; 
TS-COPD: tobacco smoke COPD. SGRQ: Saint George Respiratory Questionnaire. S: Symptoms; A: Activity; I: 
Impact; T: Total. From: González-García M, et al. Arch Bronconeumol. 2014; 50 (ALAT congress): 59 (ref. 68).
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total lung capacities (TLC) and RV/TLC ratios were significantly increased among 
both TS-COPD and non-smoking COPD (including biomass smoke COPD) sub-
jects compared to healthy subjects (p < 0.0001), with no differences between the 
two COPD groups [54]. The same study showed that patients with COPD related 
to biomass smoke had significantly higher airway resistance (sRaw values) than 
TS-COPD patients (p = 0.005) and significantly lower conductance (sGaw values) 
in biomass COPD than in TS-COPD (p = 0.010) [54].
Some studies have showed that carbon dioxide arterial pressure (PaCO2) is higher 
(lower ventilation) and oxygen arterial pressure (PaO2) and oxygen hemoglobin 
saturation (SaO2) are lower in WS-COPD than in TS-COPD [48, 61, 62, 65, 69]. 
Interestingly, Olloquequi et al. described that COPD patients who have had mixed 
exposure to tobacco smoke as well as biomass smoke had lower oxygen saturation 
than those who were exposed only to cigarette smoke or biomass smoke [72]. The 
lower oxygenation rates observed in WS-COPD may be explained by the compro-
mise of the small airways and/or by hypoventilation. It remains to be determined if 
the higher BMI in these patients, most of whom are women over 50 years of age, is 
involved in this behavior.
One of most consistent differences between WS-COPD and TS-COPD is the 
significantly lower compromise of the diffusion capacity (DLCO) in WS-COPD. 
DLCO and DLCO/alveolar volume (DLCO/VA) ratio are normal or mildly altered 
in WS-COPD patients compared to TS-COPD patients, in who these parameters 
are significantly reduced [49, 60, 61], and occurs at all levels of COPD sever-
ity (Figure 2A and B) [61]. This finding correlates well with the lower grade of 
emphysema found on computed tomography (CT) in patients with WS-COPD in 
comparison with TS-COPD [48, 49, 54, 73]. The mildly reduced DLCO with normal 
DLCO/VA found in women with WS-COPD has been described in patients with 
significantly compromised small airways with little emphysema (pseudophysi-
ological emphysema) [74]. The correlation between the level of decrease of FEV1 
and the level of DLCO reduction is significantly better in women with TS-COPD 
than in those with WS-COPD, highlighting the greater contribution of emphysema 
to airflow obstruction in TS-COPD (Figure 3) [61].
Differences in bronchial hyperresponsiveness. Women with WS-COPD have 
greater bronchial hyperresponsiveness than women with TS-COPD (Figure 4) [64]. 
Figure 2. 
Comparison of diffusion capacity between WS-COPD and TS-COPD according to degree of 
obstruction. A. DLCO (%) and B. DLCO/VA (%). In TS-COPD, DLCO and DLCO/VA are more significantly 
compromised than in WS-COPD. DLCO/VA is normal in WS-COPD at all levels of severity. WS: wood smoke; 
TS: tobacco smoke; DLCO: carbon monoxide diffusing capacity; VA: alveolar volume.From: González-García 
M, et al. Acta Med Colomb. 2004; 29: 17–25 (Ref. 61).
7
Chronic Obstructive Pulmonary Disease Related to Wood and Other Biomass Smoke: A Different…
DOI: http://dx.doi.org/10.5772/intechopen.96485
This finding could be correlated to the higher frequency of the asthma-COPD overlap 
phenotype described in biomass-related COPD [63].
Differences in exercise tolerance. Some studies which included the 6-minute walk-
ing test found no significant differences in distances walked between patients with 
WS-COPD and TS-COPD [48, 65, 68]. However, the study carried out by Zhao et al. 
found that patients exposed to biomass smoke walked fewer meters in the 6-minute 
walk than those with TS-COPD [46].
Tomography and histological differences. Patients with WS-COPD have con-
sistently less emphysema and more airway changes (bronchial and peribronchial 
thickening and fibrosis, bronchiectasis, segmental and laminar subsegmental atel-
ectasis, mosaic perfusion pattern, parenchymal bands) than patients with TS-COPD 
on both chest tomography and histological studies [48–50, 52, 60, 69, 73] (Figure 5). 
Bronchial and lung biopsies from patients with WS-COPD show significant inflam-
mation and thickening of the bronchial wall, mainly of its basal membrane, squamous 
cell metaplasia with a remarkable anthracotic pigment deposition in the bronchi and 
pulmonary interstitium [60, 75–77].
Differences in the distribution of clinical phenotypes. Golpe et al. evaluated 
the frequency of clinical phenotypes defined by the 2014 Spanish COPD guidelines 
[78] in patients with COPD caused by biomass or tobacco smoke. They found a 
greater frequency of emphysema phenotype in TS-COPD and a more common 
asthma-COPD overlap phenotype in biomass COPD, but the difference disappeared 
after adjusting for sex [63]. These differences fit perfectly with the findings of the 
studies reported so far in this chapter. No difference was found in the frequencies of 
chronic bronchitis or exacerbator phenotypes [63].
Differences in pulmonary hypertension. Sertogullarindan et al. found that 
pulmonary hypertension (PH) on echocardiography was more common in 
WS-COPD than in TS-COPD patients [79]. In previous studies, our group, based 
Figure 3. 
Correlation between FEV1 (%) and DLCO by exposure. Greater correlation is observed between FEV1 
and DLCO in TS-COPD (P < .001, r = 0.599) than in WS-COPD (P = .014, r = 0.320). WS: Wood smoke; 
TS: Tobacco smoke; DLCO: carbon monoxide diffusing capacity; FEV1: forced expiratory volume in 1 s.From: 
González-García M, et al. Acta Med Colomb. 2004; 29: 17–25 (ref. 61).
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on radiographic evaluation, suggested the same higher frequency of PH in patients 
with severe WS-COPD [61], and Sandoval et al. showed a high rate of PH and cor 
pulmonale among patients with long-term domestic exposure to wood smoke [80]. 
It has been posed that the PH observed in WS-COPD could be associated not only 
to airflow obstruction and hypoxemia, but to a direct inflammatory effect of the 
inhaled smoke. It has been described that mice exposed to biomass exhibited more 
perivascular inflammation than those exposed to cigarette smoke [81].
Differences in the frequency of bronchial anthracofibrosis. The incidence of 
bronchial anthracofibrosis and its severity in individuals exposed to wood smoke 
or tobacco smoke has not been evaluated in prospective studies, and no differences 
are known. However, marked anthracofibrosis is commonly encountered in the 
airway of subjects exposed to wood smoke [16, 55–57], sometimes accompanied 
by bronchial stenosis, and it seems more frequent and severe than in tobacco 
smoke exposed. A significant proportion of these patients have chronic airflow 
limitation and meet the functional criteria of COPD [55] possibly due to the small 
airways compromise aggravated by anthracofibrotic central airway stenosis. It is 
currently impossible to ascertain if bronchial anthracofibrosis is another feature 
of WS-COPD that appears more commonly and in a more severe form than in 
TS-COPD, or if it is a specific entity accompanied by obstruction.
Differences in survival and frequency of exacerbations. After adjusting for 
age, sex, and disease severity, no differences have been found in survival between 
WS-COPD and TS-COPD [65, 82].
Recently, Cho et al., among 1033 patients with COPD, have shown that patients 
with COPD associated with biomass smoke and those with COPD associated 
with tobacco smoke had a similar risk of exacerbations [67], confirming previous 
observations [63].
Figure 4. 
Bronchial hyperresponsiveness evaluated by PC20 by exposure. PC20: methacholine concentration 
causing ≥ 20% reduction in FEV1. White circles: WS-COPD; black circles: TS-COPD. PC20 geometric mean: 
WS-COPD versus TS-COPD: 0.39 (0.06–5.13) versus 1.24 (0.34–9.39), P = .028. WS: wood smoke; TS: tobacco 
smoke. From: Gonzalez-Garcia M, et al. Int J Chron Obstruct Pulmon Dis. 2012; 7: 367–373 (Ref. 64).
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Differences in inflammatory profile and pathophysiological ways. It is 
expected that the greater airway inflammatory involvement and the lower rate of 
emphysema in biomass COPD, including WS-COPD, compared to TS-COPD have 
an etiological, pathogenic and physiopathological basis. However, although there is 
a growing information about the pathogenic mechanisms in COPD due to biomass 
smoke exposure [83], it is not clear what are the reasons explaining its differences 
Figure 5. 
Tomographic differences between smoking and non-smoking COPD. Differences between smoker COPD 
(S-COPD) (n = 38) and non-smoker COPD (NS-COPD) (n = 70) on inspiratory-expiratory high resolution 
computerized tomography (HRCT) imaging (A) Showing HRCT classification of smoker and non-smoker 
COPD, including airway disease (black bars), emphysema (open bars) and interstitial lung abnormality 
(ILA) predominance (gray bars); (B) dot plot for emphysema and decreased attenuation of expiratory CT 
in S-COPD (■) and NS=COPD (△) compared to healthy subjects (●), where bars indicate median and 
interquartile rages and * p < 0.05, (C) Representative HRCT images of Smoker-COPD showing extensive 
centrilobular emphysema in the upper lobes and non-smoker COPD showing generalized decreased attenuation 
and some bronchial wall thickening. From: Salvi SS, et al. phenotypic comparison between smoking and non-
smoking chronic obstructive pulmonary disease. Respiratory Research. 2020; 21: 50 [64].
Chronic Obstructive Pulmonary Disease - A Current Conspectus
10
with TS-COPD. Some studies have focused on looking for differences in the type of 
inflammation and the proteolytic activity, and recently the gene expression.
The exposure to biomass smoke induces pulmonary macrophages and mononu-
clear and polynuclear cells to generate numerous inflammatory mediators, includ-
ing interleukin-6 (IL-6), interleukin-8 (IL-8), monocyte chemoattractant protein 
1 (MCP-1), macrophage inflammatory protein 2 (MIP2) and tumoral necrosis 
factor (TNF) [83, 84]. These can generate a second wave of mediators that include 
enzymes, such as matrix metalloproteinase 9 (MMP-9) and matrix metalloprotein-
ase 12 (MMP-12) involved in proteolysis and tissue remodeling typical of COPD. 
A recent study explored differences in chemokine and cytokine concentrations 
among biomass-COPD versus TS-COPD and exposed controls without COPD. The 
author identified CCL27 and CXCL13 as putative, plausibly homeostatic/protective 
biomarkers for biomass COPD [85].
Golpe et al. found that serum IL-6, IL-8, IL-5 were significantly higher in 
TS-COPD patients than in biomass COPD without differences in serum IL-13, 
periostin, surfactant protein-P, TNF-α, IgE, erythrocyte sedimentation rate, 
C-reactive protein and fibrinogen [86]. The level of exhaled nitric oxide (FeNO) 
was higher in biomass COPD (39.0 ± 14.6 ppb) than in TS-COPD (27.6 ± 16.3 ppb); 
although the difference did not reach the statistical significance level, it was 
borderline (p: 0.056) and it could be related to a small sample size [86].
A study by Solleiro-Villavicencio et al., done in women with COPD and healthy 
controls, found that IL-4 and TH2 cells were significantly higher in biomass COPD 
than in TS-COPD [87]. Frequency of TH17 cells in patients with TS-COPD was 
significantly higher than in patients with biomass COPD. They suggested that a TH2 
cytokine inflammatory profile could predominate in biomass COPD [87]. Although 
the majority the authors have not found differences in blood eosinophils counts 
between biomass COPD and TS-COPD, Fernandes et al., using a cutoff of ≥3%, 
found more frequent sputum eosinophilia in biomass COPD than in TS-COPD [88]. 
In the same way of the responses TH2, Olloquequi et al. found higher levels of total 
IgE in patients with biomass smoke COPD than in TS-COPD (Figure 6) [72].
It seems clear that the development and clinical course of COPD depend on an 
interaction between genetic and environmental factors. The gene regulation and 
expression are fundamentally involved in the pathophysiology of COPD and it is 
known that microRNAs (miRNAs) participate in the control of post-transcriptional 
regulation in TS-COPD. Recently, Velasco-Torres et al. have described the dif-
ferential role of miR-34a (downregulated) [89] and of the axis miR-22 - histone 
deacetylase activity (HDAC4) – IL-17 [90]. This axis has been linked to the devel-
opment of emphysema in rats. Serum miR-22-3p was downregulated in biomass 
COPD-BS relative to COPD-TS. In contrast, the concentration of HDAC4 was higher 
in biomass and exhibited a significant positive correlation with DLCO% [90]. This 
mechanism could be involved in the lower expression of emphysema in WS-COPD.
In summary, inflammation in biomass COPD, including WS-COPD, could be 
different from that in TS-COPD with a possible predominance of TH2 profile, and 
the lower generation of emphysema could be related to a particular and different 
response to biomass smoke.
Differences in therapeutic interventions. Almost all the studies on pharmaco-
logical interventions in COPD supporting clinical guidelines and strategies [91] 
have been done in developed countries and use the exposure to tobacco smoke as 
inclusion criteria. So, the derived evidence could not be extrapolated to other causes 
of COPD. Taking into account the different type of inflammation, higher bronchial 
hyperresponsiveness and higher frequency of the asthma-COPD overlap pheno-
type, it is expected a benefit role of inhaled corticosteroids. To our best knowledge, 
there is only one study in a small sample of patients that showed better results in 
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reducing the exacerbation frequency and improving lung function in patients with 
WS-COPD with the use of ICS [92]. So, there is a lack of information regarding the 
efficacy and safety of pharmacological interventions in patients with WS-COPD, 
particularly on the potential benefits of the use of ICS in these patients.
3. COPD related to biomass fuels different from wood smoke
Biomass fuels used for cooking include mainly wood, charcoal, agricultural 
residues, and animal dung. The composition of these types of biomass and the 
smoke derived from burning it significantly differ [93]. There is growing informa-
tion about the different animal and human responses to the exposures to different 
kind of the biomass fuels. As we have presented in this chapter, probably the most 
studied biomass smoke and the responses to its inhalation is wood [94, 95]. Animal 
manure contains greater diversity and greater quantities of microorganisms and 
the inflammatory response could be different [81, 96, 97]. Dung biomass smoke 
[96] activates inflammatory responses in human epithelial cells from airways. Cow 
dung exposure, but not wood smoke exposure, mediated a measurable increase in 
non-tipeable Haemophilus influenzae adhesion to airway epithelial cells.
Most of the epidemiologic, systematic reviews and meta-analysis group these 
types of fuels as the generic term “biomass” studies. The distribution of the types 
of biomass fuels used for cooking differ depending on the country and region. In 
certain regions, wood or wood and charcoal are the only or most used fuel but in 
other ones it could predominate animal dung or agricultural residues. One study 
in Tanzania shows that 99.5% of participants had exposure to biomass: 92.4% used 
wood, 14.9% used charcoal, 1.5% used crop residues and 0.6% used animal dung 
for cooking and heating purposes [98].
Studies that have characterized COPD, this means that have described the 
clinical, functional, radiographic and histopathological characteristics, have been 
done in wood smoke exposed, and those that have grouped patients under “biomass” 
Figure 6. 
IgE levels in COPD due to tobacco smoke, wood smoke or both. α: Different from control subjects 
(p < 0.05).β: Different from TS COPD group (p < 0.05). TS: Tobacco smoke; WS: Wood smoke. From: 
Olloquequi J, et al. Respiratory Research (2018) 19:13 [72].
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exposed or “non-smokers” have included mainly people exposed to wood smoke. 
Therefore, it is possible that the COPD related to dung or crop residues be different 
and it is not recommendable to generalize the observations done in WS-COPD and 
described in this chapter to other types of biomass fuels.
4.  Respiratory disease due to indoor chronic exposure to wood smoke: a 
different phenotype of COPD or a separable disease?
COPD is defined using a functional criterion and an unspecific exposure. So, 
under this term can be included a very numerous and heterogenous pathologic 
conditions. Accepting the weakness of the definition of COPD as a disease (it is 
more a syndrome), the WS-COPD (it is not sure if all type of biomass COPD) 
could be accepted as a phenotype of COPD. However, if we assume that etiology is 
different (wood smoke is not cigarette smoke), the inflammatory responses and the 
pathophysiologic could be different, and the clinical, functional and histopatho-
logic expression are also different, the chronic respiratory disease due to long-term 
indoor exposure to wood smoke is better understood as a separate nosology entity. 
Most importantly the actions for prevention significantly differ and the therapeutic 
interventions could be also different.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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